A cheap gout medication, colchicine, shows significant promise in preventing heart attacks and strokes for individuals with existing heart disease. A new Cochrane review highlights its ability to reduce cardiovascular events by stabilizing inflamed blood vessels. This repurposing of an old drug offers a cost-effective and safer approach to secondary prevention, potentially saving thousands of lives.
